SCM
KALA icon

Silverarc Capital Management’s KALA BIO KALA Stock Holding History

Silverarc Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,922
Closed -$1.41M – 75
2025
Q1 		$1.41M Buy
4,922
+301
+7% +$114K 0.29% 55
2024
Q4 		$1.6M Buy
+4,621
New +$1.46M 0.35% 50
2021
Q2 		– Sell
-41
Closed -$689K – 108
2021
Q1 		$689K Hold
41
– – 0.38% 62
2020
Q4 		$693K Buy
+41
New +$771K 0.4% 62

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Silverarc Capital Management's KALA Position: Q2 2025 in Review

Silverarc Capital Management sold out of KALA BIO (KALA) in Q2 2025, closing a stake of 4,922 shares — an estimated $1.41M sold.

Silverarc Capital Management first reported a position in KALA in Q4 2020 and held it in 4 quarters. The position peaked at $1.6M in Q4 2024. 27 funds tracked by Wall St. Rank hold KALA as of Q2 2025.

  • Silverarc Capital Management reported no remaining KALA BIO position as of Q2 2025 after selling out during the quarter.
  • Silverarc Capital Management sold 4,922 KALA BIO shares in Q2 2025, an estimated $1.41M.
  • Silverarc Capital Management first reported a position in KALA BIO in Q4 2020 and held it in 4 quarters.
  • Silverarc Capital Management's KALA BIO position peaked at $1.6M in Q4 2024.
  • 27 funds tracked by Wall St. Rank held KALA BIO as of Q2 2025.

Based on Silverarc Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.